In this episode, Thomas Bertels and John Glasspool discuss the importance of collaboration to build successful, purpose-driven teams. John is the current CEO of Anthos Therapeutics, a clinical-stage biopharmaceutical company, and an MIT advisor and a board member. Prior to Anthos, he served as a senior executive at Baxalta, Baxter, Novartis, and J&J.       

In the conversation, John lays out the argument why collaboration is so crucial for biopharma companies and what the benefits of a collaborative culture are,  challenges common perceptions about the downside of collaboration, and provides a framework for how to start building such a culture.